Smoking cessation interventions for adults aged 50 or older: A systematic review and meta-analysis

Drug and Alcohol Dependence

Volumn 154, Issue , 2015, Pages 14-24

  Chen, Danhong ^a   Wu, Li Tzy ^a,b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

Meta analysis; Older adults; Smoking cessation interventions; Weighted least squares meta regression

Indexed keywords

ADULT; CLINICAL EFFECTIVENESS; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; MIDDLE AGED; PATIENT CARE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SMOKING CESSATION; SMOKING CESSATION PROGRAM; SYSTEMATIC REVIEW; TREATMENT OUTCOME; AGE; DRUG THERAPY; MULTIMODALITY CANCER THERAPY; ODDS RATIO; PROCEDURES; SMOKING; STATISTICS AND NUMERICAL DATA; THERAPY;

AGE FACTORS; COMBINED MODALITY THERAPY; HUMANS; MIDDLE AGED; ODDS RATIO; SMOKING; SMOKING CESSATION;

EID: 84938961239     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2015.06.004     Document Type: Review

References (55)

1. Abdullah A.S.M., Simon J.L. Health promotion in older adults: evidence-based smoking cessation programs for use in primary care settings. Geriatrics 2006, 61:30-34.
2. Agaku I.T., King B.A., Dube S.R. Current cigarette smoking among adults-United States, 2005-2012. MMWR 2014, 63:29-34.
3. APA, 2006. Practice guideline for the treatment of patients with substance use disorders second edition. 〈http://psychiatryonline.org/pdfaccess.ashx?ResourceID=243188&PDFSource=6〉 (accessed 08.10.14).
4. Baker W.L., Michael White C., Cappelleri J.C., Kluger J., Coleman C.I. Understanding heterogeneity in meta-analysis: the role of meta-regression. Int. J. Clin. Pract. 2009, 63:1426-1434. Health Outcomes, Policy, and Economics (HOPE) Collaborative Group.
5. Cameron A.C., Trivedi P.K. Microeconometrics Using Stata 2010, (Revised Edition), Stata Press, Texas.
6. Carroll K.M., Kosten T.R., Rounsaville B.J. Choosing a behavioral therapy platform for pharmacotherapy of substance users. Drug Alcohol Depend. 2004, 75:123-134.
7. Quitting smoking among adults-United States, 2001-2010. MMWR 2011, 60:1513-1519. CDC.
8. Cepeda-Benito A., Reynoso J.T., Erath S. Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: differences between men and women. J. Consult. Clin. Psychol. 2004, 72:712-722.
9. Costello M., Sproule B., Victor J.C., Leatherdale S., Zawertailo L., Selby P. Effectiveness of pharmacist counseling combined with nicotine replacement therapy: a pragmatic randomized trial with 6,987 smokers. Cancer Causes Control 2011, 22:167-180.
10. Dale L.C., Glover E.D., Sachs D.P.L., Schroeder D.R., Offord K.P., Croghan I.T., Hurt R.D. Bupropion for smoking cessation: predictors of successful outcome. Chest 2001, 119:1357-1364.
11. The Health Consequences Of Smoking-50 Years Of Progress: A Report Of The Surgeon General 2014, DHHS, US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA.
12. Doll R., Peto R., Boreham J., Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. Br. Med. J. 2004, 328:1519.
13. Doolan D.M., Froelicher E.S. Smoking cessation interventions and older adults. Prog. Cardiovasc. Nurs. 2008, 23:119-127.
14. Doolan D.M., Stotts N.A., Benowitz N.L., Covinsky K.E., Froelicher E.S. The women's initiative for nonsmoking (WINS) XI: age-related differences in smoking cessation responses among women with cardiovascular disease. Am. J. Geriatr. Cardiol. 2008, 17:37-47.
15. Egger M., Smith G.D., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. Br. Med. J. 1997, 315:629-634.
16. Ferketich A.K., Otterson G.A., King M., Hall N., Browning K.K., Wewers M.E. A pilot test of a combined tobacco dependence treatment and lung cancer screening program. Lung Cancer 2012, 76:211-215.
17. Fiore M., Jaen C.R., Baker T., Bailey W., Benowitz N., Curry S., Dorfman S., Froelicher E., Goldstein M., Healton C. Treating tobacco use and dependence: 2008 update. A U.S. public health service report. Am. J. Prev. Med. 2008, 35:158-176.
18. Guyatt G.H., Oxman A.D., Schünemann H.J., Tugwell P., Knottnerus A. GRADE guidelines: a new series of articles in the journal of clinical epidemiology. J. Clin. Epidemiol. 2011, 64:380-382.
19. Hall S.M., Humfleet G.L., Muñoz R.F., Reus V.I., Robbins J.A., Prochaska J.J. Extended treatment of older cigarette smokers. Addiction 2009, 104:1043-1052.
20. Harbord R.M., Harris R.J., Sterne J.A. Updated tests for small-study effects in meta-analyses. Stata J. 2009, 9:197.
21. Harris M., Bayer A., Tadd W. Addressing the information needs of older patients. Rev. Clin. Gerontol. 2002, 12:5-11.
22. Hedges L.V., Vevea J.L. Fixed-and random-effects models in meta-analysis. Psychol. Methods 1998, 3:486.
23. Higgins J., Thompson S.G. Controlling the risk of spurious findings from meta-regression. Stat. Med. 2004, 23:1663-1682.
24. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. Br. Med. J. 2003, 327:557.
25. Hill R.D., Rigdon M., Johnson S. Behavioral smoking cessation treatment for older chronic smokers. Behav. Ther. 1993, 24:321-329.
26. Hughes J.R., Keely J.P., Niaura R.S., Ossip-Klein D.J., Richmond R.L., Swan G.E. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob. Res. 2003, 5:13-25.
27. James C., James N., Davies D., Harvey P., Tweddle S. Preferences for different sources of information about cancer. Patient Educ. Couns. 1999, 37:273-282.
28. Joyce G.F., Niaura R., Maglione M., Mongoven J., Larson-Rotter C., Coan J., Lapin P., Morton S. The effectiveness of covering smoking cessation services for medicare beneficiaries. Health Serv. Res. 2008, 43:2106-2123.
29. Levin K.A. Study design VII. Randomised controlled trials. Evid.-Based Dent. 2007, 8:22-23.
30. McFall M., Saxon A.J., Malte C.A., et al. Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. J. Am. Med. Assoc. 2010, 304:2485-2493.
31. Moher D., Hopewell S., Schulz K.F., Montori V., Gøtzsche P.C., Devereaux P., Elbourne D., Egger M., Altman D.G. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. J. Clin. Epidemiol. 2010, 63:e1-e37.
32. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Br. Med. J. 2009, 339:332-336.
33. Moreno S.G., Sutton A.J., Ades A.E., Stanley T.D., Abrams K.R., Peters J.L., Cooper N.J. Assessment of regression-based methods to adjust for publication bias through a comprehensive simulation study. BMC Med. Res. Methodol. 2009, 9.
34. Munafò M., Bradburn M., Bowes L., David S. Are there sex differences in transdermal nicotine replacement therapy patch efficacy? A meta-analysis. Nicotine Tob. Res. 2004, 6:769-776.
35. Noonan D., Jiang Y., Duffy S.A. Utility of biochemical verification of tobacco cessation in the department of veterans affairs. Addict. Behav. 2013, 38:1792-1795.
36. Orleans C.T., Boyd N.R., Noll E., Crosette L., Glassman B. Computer tailored intervention for older smokers using transdermal nicotine. Tob. Control 2000, 9:i53.
37. Ossip-Klein D.J., Carosella A.M., Krusch D.A. Self-help interventions for older smokers. Tob. Control 1997, 6:188-193.
38. Palmer T.M., Peters J.L., Sutton A.J., Moreno S.G. Contour-enhanced funnel plots for meta-analysis. Stata J. 2008, 8:242-254.
39. Perkins K.A., Scott J. Sex differences in long-term smoking cessation rates due to nicotine patch. Nicotine Tob. Res. 2008, 10:1245-1251.
40. Pilowsky D., Wu L.T. Tobacco use cessation. Substance Use and Older People 2014, 212-222. (Chapter 15), John Wiley & Sons, Ltd., UK. I. Crome, L.T. Wu, R. Rao, P. Crome (Eds.).
41. Porta M. Publication bias. A Dictionary of Epidemiology 2008, Oxford University Press, New York, NY, http://www.oxfordreference.com.proxy.lib.duke.edu/view/10.1093/acref/9780195314496.001.0001/acref-9780195314496-e-1542 (accessed 08.10.14). M. Porta (Ed.).
42. Rigotti N.A., Regan S., Levy D.E., Japuntich S., Chang Y., Park E.R., Viana J.C., Kelley J.H., Reyen M., Singer D.E. Sustained care intervention and postdischarge smoking cessation among hospitalized adults: a randomized clinical trial. J. Am. Med. Assoc. 2014, 312:719-728.
43. Rimer B.K., Orleans C.T., Fleisher L., Cristinzio S., Resch N., Telepchak J., Keintz M.K. Does tailoring matter? The impact of a tailored guide on ratings and short-term smoking-related outcomes for older smokers. Health Educ. Res. 1994, 9:69-84.
44. Rostron B.L., Chang C.M., Pechacek T.F. Estimation of cigarette smoking-attributable morbidity in the United States. JAMA Intern. Med. 2014, 174:1922-1928.
45. Shiffman S., Brockwell S.E., Pillitteri J.L., Gitchell J.G. Individual differences in adoption of treatment for smoking cessation: demographic and smoking history characteristics. Drug Alcohol Depend. 2008, 93:121-131.
46. Stanley T., Doucouliagos, H., 2013. Better than random: weighted least squares meta-regression analysis. Deakin Working Paper No. 2013_2, Deakin University. 〈〉 (accessed 08.10.14). http://www.deakin.edu.au/buslaw/aef/workingpapers/papers/2013_2.pdf.
47. Stead L.F., Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst. Rev. 2012, 10:CD008286.
48. Sterne J.A., Gavaghan D., Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J. Clin. Epidemiol. 2000, 53:1119-1129.
49. Tashkin D.P., Rennard S., Hays J.T., Ma W., Lawrence D., Lee T.C. Effects of varenicline on smoking cessation in patients with mild to moderate copd: a randomized controlled trial. Chest 2011, 139:591-599.
50. Thompson S.G., Sharp S.J. Explaining heterogeneity in meta-analysis: a comparison of methods. Stat. Med. 1999, 18:2693-2708.
51. Torchalla I., Okoli C.T.C., Hemsing N., Greaves L. Gender differences in smoking behaviour and cessation. J. Smok. Cessat. 2011, 6:9-16.
52. Vetter N.J., Ford D. Smoking prevention among people aged 60 and over: a randomized controlled trial. Age Ageing 1990, 19:164-168.
53. Vincent G.K., Velkoff V.A. The Next Four Decades: The Older Population in the United States: 2010 to 2050 2010, US Department of Commerce, Economics and Statistics Administration, US Census Bureau, Washington, DC.
54. Vickers A., Goyal N., Harland R., Rees R. Do certain countries produce only positive results? A systematic review of controlled trials. Control. Clin. Trials 1998, 19:159-166.
55. Zbikowski S.M., Magnusson B., Pockey J.R., Tindle H.A., Weaver K.E. A review of smoking cessation interventions for smokers aged 50 and older. Maturitas 2012, 71:131-141.